Krane Funds Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-15,353
Closed -$771K 343
2021
Q4
$771K Buy
15,353
+2,932
+24% +$152K 0.02% 92
2021
Q3
$659K Sell
12,421
-2,766
-18% -$156K 0.01% 119
2021
Q2
$927K Buy
+15,187
New +$807K 0.03% 84

Other funds holding LMAT

Krane Funds Advisors's LMAT Position: Q1 2022 in Review

Krane Funds Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2022, closing a stake of 15,353 shares — an estimated $771K sold.

Krane Funds Advisors first reported a position in LMAT in Q2 2021 and held it in 3 quarters. The position peaked at $927K in Q2 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q1 2022.

  • Krane Funds Advisors reported no remaining LeMaitre Vascular position as of Q1 2022 after selling out during the quarter.
  • Krane Funds Advisors sold 15,353 LeMaitre Vascular shares in Q1 2022, an estimated $771K.
  • Krane Funds Advisors first reported a position in LeMaitre Vascular in Q2 2021 and held it in 3 quarters.
  • Krane Funds Advisors's LeMaitre Vascular position peaked at $927K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2022.

Based on Krane Funds Advisors's 13F filing for Q1 2022, filed 11 May 2022.